146 related articles for article (PubMed ID: 24222125)
21. PAX-2 is a helpful marker for diagnosing metastatic renal cell carcinoma: comparison with the renal cell carcinoma marker antigen and kidney-specific cadherin.
Ozcan A; Zhai Q; Javed R; Shen SS; Coffey D; Krishnan B; Truong LD
Arch Pathol Lab Med; 2010 Aug; 134(8):1121-9. PubMed ID: 20670131
[TBL] [Abstract][Full Text] [Related]
22. Correlation between interleukin 6 production and tumor proliferation in non-small cell lung cancer.
Yamaji H; Iizasa T; Koh E; Suzuki M; Otsuji M; Chang H; Motohashi S; Yokoi S; Hiroshima K; Tagawa M; Nakayama T; Fujisawa T
Cancer Immunol Immunother; 2004 Sep; 53(9):786-92. PubMed ID: 15185009
[TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of tenascin-C expression in clear cell renal cell carcinoma.
Ohno Y; Izumi M; Yoshioka K; Ohori M; Yonou H; Tachibana M
Oncol Rep; 2008 Sep; 20(3):511-6. PubMed ID: 18695899
[TBL] [Abstract][Full Text] [Related]
24. Eight proteins play critical roles in RCC with bone metastasis via mitochondrial dysfunction.
Wang J; Zhao X; Qi J; Yang C; Cheng H; Ren Y; Huang L
Clin Exp Metastasis; 2015 Aug; 32(6):605-22. PubMed ID: 26115722
[TBL] [Abstract][Full Text] [Related]
25. Laminin alpha1 chain in human renal cell carcinomas and integrin-mediated adhesion of renal cell carcinoma cells to human laminin isoforms.
Rissanen J; Korhonen M; Lehto VP; Virtanen I
J Pathol; 2003 Jun; 200(2):157-67. PubMed ID: 12754736
[TBL] [Abstract][Full Text] [Related]
26. Mucinous tubular and spindle cell carcinoma of the kidney with sarcomatoid change.
Dhillon J; Amin MB; Selbs E; Turi GK; Paner GP; Reuter VE
Am J Surg Pathol; 2009 Jan; 33(1):44-9. PubMed ID: 18941398
[TBL] [Abstract][Full Text] [Related]
27. Sarcomatoid renal cell carcinoma in a young adult.
Kourda N; Zeddini A; Zaafrani MR; Zermani R; Ferchichi L; Ayed M; Jilani SB
Pathologica; 2006 Jun; 98(3):181-3. PubMed ID: 17036947
[TBL] [Abstract][Full Text] [Related]
28. Sperm-associated antigen 9 is associated with tumor growth, migration, and invasion in renal cell carcinoma.
Garg M; Kanojia D; Khosla A; Dudha N; Sati S; Chaurasiya D; Jagadish N; Seth A; Kumar R; Gupta S; Gupta A; Lohiya NK; Suri A
Cancer Res; 2008 Oct; 68(20):8240-8. PubMed ID: 18922895
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of DLC-1 induces cell apoptosis and proliferation inhibition in the renal cell carcinoma.
Zhang T; Zheng J; Jiang N; Wang G; Shi Q; Liu C; Lu Y
Cancer Lett; 2009 Sep; 283(1):59-67. PubMed ID: 19380190
[TBL] [Abstract][Full Text] [Related]
30. BMP-2 inhibits tumor growth of human renal cell carcinoma and induces bone formation.
Wang L; Park P; Zhang H; La Marca F; Claeson A; Than K; Rahman S; Lin CY
Int J Cancer; 2012 Oct; 131(8):1941-50. PubMed ID: 22275155
[TBL] [Abstract][Full Text] [Related]
31. Immunomorphological characteristics of renal cell carcinoma.
Markovic-Lipkovski J; Brasanac D; Todorovic V; Müller CA; Müller GA
Histol Histopathol; 1995 Jul; 10(3):651-9. PubMed ID: 7579814
[TBL] [Abstract][Full Text] [Related]
32. The evolution of collagen expression in sarcomatoid renal cell carcinoma.
Delahunt B; Bethwaite PB; McCredie MR; Nacey JN
Hum Pathol; 2007 Sep; 38(9):1372-7. PubMed ID: 17521699
[TBL] [Abstract][Full Text] [Related]
33. Flow cytometric analysis and motility response to laminin and fibronectin of four new metastatic variants of the human renal cell carcinoma line RC43.
Grossi FS; Keizer DM; Saracino GA; Erkens S; Romijn JC; Schröder FH
Prog Clin Biol Res; 1992; 378():195-205. PubMed ID: 1301582
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical distinction of renal cell carcinoma from other carcinomas with clear-cell histomorphology: utility of CD10 and CA-125 in addition to PAX-2, PAX-8, RCCma, and adipophilin.
Mentrikoski MJ; Wendroth SM; Wick MR
Appl Immunohistochem Mol Morphol; 2014 Oct; 22(9):635-41. PubMed ID: 25279712
[TBL] [Abstract][Full Text] [Related]
35. Spheres derived from the human SK-RC-42 renal cell carcinoma cell line are enriched in cancer stem cells.
Zhong Y; Guan K; Guo S; Zhou C; Wang D; Ma W; Zhang Y; Li C; Zhang S
Cancer Lett; 2010 Dec; 299(2):150-60. PubMed ID: 20846785
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of metastatic renal cell carcinomas expressing somatostatin receptors by a targeted cytotoxic analogue of somatostatin AN-238.
Plonowski A; Schally AV; Nagy A; Kiaris H; Hebert F; Halmos G
Cancer Res; 2000 Jun; 60(11):2996-3001. PubMed ID: 10850448
[TBL] [Abstract][Full Text] [Related]
37. Renal cell carcinoma marker (RCC-Ma) is specific for cutaneous metastasis of renal cell carcinoma.
Perna AG; Ostler DA; Ivan D; Lazar AJ; Diwan AH; Prieto VG; Reed JA
J Cutan Pathol; 2007 May; 34(5):381-5. PubMed ID: 17448192
[TBL] [Abstract][Full Text] [Related]
38. Tumor suppressor activity and epigenetic inactivation of hepatocyte growth factor activator inhibitor type 2/SPINT2 in papillary and clear cell renal cell carcinoma.
Morris MR; Gentle D; Abdulrahman M; Maina EN; Gupta K; Banks RE; Wiesener MS; Kishida T; Yao M; Teh B; Latif F; Maher ER
Cancer Res; 2005 Jun; 65(11):4598-606. PubMed ID: 15930277
[TBL] [Abstract][Full Text] [Related]
39. Characterization of a renal cell carcinoma cell line derived from a human bone metastasis and establishment of an experimental nude mouse model.
Weber KL; Pathak S; Multani AS; Price JE
J Urol; 2002 Aug; 168(2):774-9. PubMed ID: 12131367
[TBL] [Abstract][Full Text] [Related]
40. Silibinin inhibits the invasion and migration of renal carcinoma 786-O cells in vitro, inhibits the growth of xenografts in vivo and enhances chemosensitivity to 5-fluorouracil and paclitaxel.
Chang HR; Chen PN; Yang SF; Sun YS; Wu SW; Hung TW; Lian JD; Chu SC; Hsieh YS
Mol Carcinog; 2011 Oct; 50(10):811-23. PubMed ID: 21574189
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]